Earn 1 hour (0.1 CEU) of continuing education credit with the on-demand webinar, Legal Insights into GLP-1 and Peptide Compounding in 2026: FDA and Private Enforcement, State Board Compliance, and the Future of Telehealth Prescribing. As the regulatory environment for compounded GLP-1s and peptides continues to shift, pharmacy professionals must stay informed on new enforcement trends and compliance expectations. This session provides a practical overview of the legal and regulatory landscape impacting 503A pharmacies, 503B outsourcing facilities, and telehealth providers. Our expert speakers review key topics including FDA enforcement actions, State Board of Pharmacy oversight, and private litigation involving compounded GLP-1 products. The webinar also explores the impact of the end of GLP-1 shortages, current prescribing and compounding practices, and evolving risks related to telehealth and marketing activities.
